| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adjuvant tamoxifen: 5 year control of dormant disease?
|
Merimsky, O.
|
|
1996
|
32 |
1 |
p. 174-
1 p.
|
artikel
|
| 2 |
An economic model to assess the savings from a clinical application of haematopoietic growth factors
|
Groot, C.A.Uyl-de
|
|
1996
|
32 |
1 |
p. 57-62
6 p.
|
artikel
|
| 3 |
Announcement
|
|
|
1996
|
32 |
1 |
p. 1-
1 p.
|
artikel
|
| 4 |
An open randomised cross-over study on granisetron versus ondansetron in the prevention of acute emesis induced by moderate dose cisplatin-containing regimens
|
Martoni, A.
|
|
1996
|
32 |
1 |
p. 82-85
4 p.
|
artikel
|
| 5 |
Anti-oestrogen stimulation of ERBB2 ectodomain shedding from BT-474 human breast cancer cells with ERBB2 gene amplification
|
Wärri, A.M.
|
|
1996
|
32 |
1 |
p. 134-140
7 p.
|
artikel
|
| 6 |
A phase II study of paclitaxel in advanced breast cancer resistant to anthracyclines
|
Fountzilas, G.
|
|
1996
|
32 |
1 |
p. 47-51
5 p.
|
artikel
|
| 7 |
A phase II trial of fotemustine and cisplatin in central nervous system metastases from non-small cell lung cancer
|
Cotto, C.
|
|
1996
|
32 |
1 |
p. 69-71
3 p.
|
artikel
|
| 8 |
A randomised study comparing granulocyte-coiony stimulating factor (G-CSF) with G-CSF plus thymostimulin in the treatment of haematological toxicity in patients with advanced breast cancer after high dose mitoxantrone therapy
|
Sanchiz, F.
|
|
1996
|
32 |
1 |
p. 52-56
5 p.
|
artikel
|
| 9 |
Calendar of forthcoming meetings
|
|
|
1996
|
32 |
1 |
p. 187-193
7 p.
|
artikel
|
| 10 |
Cancer of the prostate in Norway 1957–1991—A descriptive study
|
Harvei, S.
|
|
1996
|
32 |
1 |
p. 111-117
7 p.
|
artikel
|
| 11 |
Cathepsin D and breast cancer
|
Westley, B.R.
|
|
1996
|
32 |
1 |
p. 15-24
10 p.
|
artikel
|
| 12 |
Chemotherapy with doxorubicin, etoposide and cyclophosphamide (DEC) in ovarian cancer persistent after platinum-based treatment
|
Zanetta, G.
|
|
1996
|
32 |
1 |
p. 178-179
2 p.
|
artikel
|
| 13 |
Corrections
|
|
|
1996
|
32 |
1 |
p. 185-186
2 p.
|
artikel
|
| 14 |
Dacarbazine, vincristine, bleomycin and lomustine plus natural interferon-alpha for metastatic melanoma
|
Reinhold, U.
|
|
1996
|
32 |
1 |
p. 180-
1 p.
|
artikel
|
| 15 |
Does age at the last birth affect breast cancer risk?
|
Hsieh, C.-C.
|
|
1996
|
32 |
1 |
p. 118-121
4 p.
|
artikel
|
| 16 |
Ectopic vasopressin expression in MMTV-v-Ha-ras transgenic mice delays the onset of mammary tumorigenesis
|
Chooi, K.-F.
|
|
1996
|
32 |
1 |
p. 122-127
6 p.
|
artikel
|
| 17 |
Editorial Board
|
|
|
1996
|
32 |
1 |
p. IFC-
1 p.
|
artikel
|
| 18 |
Expression of MHC molecules and ICAM-1 on non-small cell lung carcinomas: Association with early lymphatic spread of tumour cells
|
Passlick, B.
|
|
1996
|
32 |
1 |
p. 141-145
5 p.
|
artikel
|
| 19 |
Helping cancer patients disclose their concerns
|
Maguire, P.
|
|
1996
|
32 |
1 |
p. 78-81
4 p.
|
artikel
|
| 20 |
High frequency of urothelial cancers in patients with kidney transplantations for end-stage analgesic nephropathy
|
Bokemeyer, C.
|
|
1996
|
32 |
1 |
p. 175-176
2 p.
|
artikel
|
| 21 |
Immunostaining of human melanomas by a monoclonal antibody to B700 mouse melanoma antigen
|
Xu, X.
|
|
1996
|
32 |
1 |
p. 168-173
6 p.
|
artikel
|
| 22 |
Inhibitions of protein kinase C and proto-oncogene expressions in NIH 3t3 cells by apigenin
|
Huang, Ying-Tang
|
|
1996
|
32 |
1 |
p. 146-151
6 p.
|
artikel
|
| 23 |
International cancer news
|
|
|
1996
|
32 |
1 |
p. 3-6
4 p.
|
artikel
|
| 24 |
Lonidamine plus epirubicin and cyclophosphamide in advanced breast cancer. A phase II study
|
Gardin, G.
|
|
1996
|
32 |
1 |
p. 176-177
2 p.
|
artikel
|
| 25 |
MDR1 gene expression: Evaluation of its use as a molecular marker for prognosis and chemotherapy of bone and soft tissue sarcomas
|
Stein, U.
|
|
1996
|
32 |
1 |
p. 86-92
7 p.
|
artikel
|
| 26 |
MSH2 sequence variations and inherited colorectal cancer susceptibility
|
Froggatt, N.J.
|
|
1996
|
32 |
1 |
p. 178-
1 p.
|
artikel
|
| 27 |
Multiple drug resistance-related messenger RNA expression in archival formalin-fixed paraffin-embedded human breast tumour tissue
|
O'driscoll, L.
|
|
1996
|
32 |
1 |
p. 128-133
6 p.
|
artikel
|
| 28 |
Myocardial function in children and adolescents after therapy with anthracyclines and chest irradiation
|
Pihkala, J.
|
|
1996
|
32 |
1 |
p. 97-103
7 p.
|
artikel
|
| 29 |
Octreotide treatment of chemotherapy-induced diarrhoea
|
Ginopoulos, P.
|
|
1996
|
32 |
1 |
p. 182-183
2 p.
|
artikel
|
| 30 |
On the threshold of success? Report on ECCO8, 29 October–2 November 1995, Paris, France
|
Purves, B.C.
|
|
1996
|
32 |
1 |
p. 39-40
2 p.
|
artikel
|
| 31 |
Palliative endoscopie therapy of rectal carcinoma
|
Dohmoto, M.
|
|
1996
|
32 |
1 |
p. 25-29
5 p.
|
artikel
|
| 32 |
Quality of prostate cancer data in the Cancer Registry of Norway
|
Harvei, S.
|
|
1996
|
32 |
1 |
p. 104-110
7 p.
|
artikel
|
| 33 |
Radiolabelled mIBG in the treatment of neuroblastoma
|
Gaze, M.N.
|
|
1996
|
32 |
1 |
p. 93-96
4 p.
|
artikel
|
| 34 |
Results of a phase II trial with cystemustine in advanced malignant melanoma. A trial of the EORTC Clinical Screening Group
|
Urosevic, V.
|
|
1996
|
32 |
1 |
p. 181-182
2 p.
|
artikel
|
| 35 |
Role of oxygen free radicals in cancer development
|
Dreher, D.
|
|
1996
|
32 |
1 |
p. 30-38
9 p.
|
artikel
|
| 36 |
Selecting high-risk early breast cancer patients: What to add to the number of metastatic nodes?
|
Perrone, F.
|
|
1996
|
32 |
1 |
p. 41-46
6 p.
|
artikel
|
| 37 |
SR8—The establishment and characterisation of a new ovarian carcinoma cell line and xenograft model
|
Han, X.
|
|
1996
|
32 |
1 |
p. 160-167
8 p.
|
artikel
|
| 38 |
The antimetabolite tiazofurin (TR) inhibits glycoconjugate biosynthesis and invasiveness of tumour cells
|
Tímár, J.
|
|
1996
|
32 |
1 |
p. 152-159
8 p.
|
artikel
|
| 39 |
The breast screening controversy
|
Baum, M.
|
|
1996
|
32 |
1 |
p. 9-11
3 p.
|
artikel
|
| 40 |
The prognostic value of cathepsin D in breast cancer. A long road to the clinic
|
Rochefort, H.
|
|
1996
|
32 |
1 |
p. 7-8
2 p.
|
artikel
|
| 41 |
The prognostic value of serum and immunohistochemical tumour markers in advanced gastric cancer
|
Webb, A.
|
|
1996
|
32 |
1 |
p. 63-68
6 p.
|
artikel
|
| 42 |
The quality of life of patients with newly diagnosed M1 prostate cancer: Experience with EORTC clinical trial 30853
|
da Silva, F.C.
|
|
1996
|
32 |
1 |
p. 72-77
6 p.
|
artikel
|
| 43 |
Upper age limit for cervical cancer screening
|
Cecchini, S.
|
|
1996
|
32 |
1 |
p. 180-
1 p.
|
artikel
|
| 44 |
What do we know on variables influencing clinical decision-making in elderly cancer patients?
|
Monfardini, S.
|
|
1996
|
32 |
1 |
p. 12-14
3 p.
|
artikel
|
Tijdschrift beschrijving